Skip to content

Audiological Benefit With Non-implantable Bone Conduction Hearing Systems

Audiological Benefit With Non-implantable Bone Conduction Hearing Systems

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03129191
Enrollment
15
Registered
2017-04-26
Start date
2017-07-01
Completion date
2017-11-06
Last updated
2017-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Conductive

Brief summary

Recently, a new non-invasive bone conduction hearing aid was introduced. The system is connected directly to the skin with an adhesive adapter to transmit the sound to the inner ear through bone vibrations. The objective of this study is to evaluate and compare the audiological benefit of the new bone conduction hearing aid and compare it to an existing bone conduction hearing aid in normal hearing adults with bilateral simulated conductive hearing loss. An evaluation of the improvement on speech understanding in noise and sound localization allows to estimate the system performance and enables to derive recommendations for clinical usage of the novel hearing system. It is hypothesized that in the bilateral condition similar speech understanding in noise and sound localization performance can be achieved with the new system compared to existing bone conduction hearing aids that are pressed against the skull using a soft band.

Interventions

DEVICENon-invasive bone conduction hearing aid A

The intervention is a non-invasive bone conduction hearing device which is retained on the patient's head with an elastic headband.

DEVICENon-invasive bone conduction hearing aid B

The intervention is a non-invasive bone conduction hearing device which is retained on the patient's head with an adhesive adapter that is placed behind the auricle.

Sponsors

Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Written informed consent * Adults (age ≥ 18 years on the test date) * Normal hearing thresholds (AC/BC-thresholds ≤ 20 dB HL, 0.25 to 8 kHz) * German native speakers * Willingness and ability to perform all tests required for the study

Exclusion criteria

* Lack of compliance with any inclusion criteria * Allergy against silicon (ear mold casting mass)

Design outcomes

Primary

MeasureTime frameDescription
Speech reception threshold in noise (S0NDIFF)Day 1Speech reception threshold in noise (in dB SNR) measured with speech presented from the front (0° azimuth) and approximated diffuse noise presented from 4 speakers.

Secondary

MeasureTime frameDescription
Speech reception threshold in noise (S90NDIFF)Day 1Speech reception threshold in noise (in dB SNR) measured with speech presented from the right side (90° azimuth) and approximated diffuse noise presented from 4 speakers.
Speech reception threshold in noise (S270NDIFF)Day 1Speech reception threshold in noise (in dB SNR) measured with speech presented from the left side (270° azimuth) and approximated diffuse noise presented from 4 speakers.
Sound localizationDay 1Mean absolute localization error (in degrees)
Subjective evaluation of the sound qualityDay 1Assessment of the sound quality with questionnaire by Gabrielsson et al.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026